Author

Juntao Yu

Howard Hughes Medical InstituteORCID 0000-0003-3282-2781Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:multiome· 1 Organism:non-human primate· 1

Frequent Co-Authors

Antonis Tatarakis· 1 shared Carlos A. Pinzón-ArteagaiD· 1 shared Chaoting ZhangiD· 1 shared Danesh MoazediD· 1 shared Harleen SainiiD· 1 shared Qiang ChengiD· 1 shared Qiu WangiD· 1 shared Quan LiiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperDevelopmental Biology

Antonis Tatarakis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Developmental BiologyMolecular CellPeer-reviewedSep 1, 2025

Requirements for establishment and epigenetic stability of mammalian heterochromatin

Antonis Tatarakis, Harleen Saini, Juntao Yu…·Danesh Moazed

This study identifies factors required for establishing and maintaining mammalian heterochromatin, showing that DHX9 and H3K9me erasers influence its stability during differentiation.

21 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky

BioengineeringBiomaterialsPeer-reviewedDec 24, 2024

Targeted LNPs deliver mRNA encoding IL-15 superagonists to balance efficacy and toxicity in cancer therapy

Juntao Yu, Quan Li, Chaoting Zhang…·Qiang Cheng

This study uses targeted mRNA-LNPs to deliver IL-15 superagonists, improving anti-tumor efficacy while reducing toxicity compared to existing therapies.

29 citations

non-human primatemultiome

𝕏 PostBluesky